Abstract

This study aimed to examine the radioprotective effect of polydatin (PD) on crypt and endothelial cells of the small intestines of C57BL/6 mice that received abdominal irradiation (IR). Mice were treated with 6 MV X-ray (20 Gy) abdominal IR at a dose rate of 200 cGy/min. Thirty minutes before or after IR, mice were intraperitoneally injected with PD. The rate of survival of the mice at 30 days after IR was determined. The duodenum (upper small intestine), jejunum (middle small intestine), and ileum (lower small intestine) were collected and subjected to hematoxylin and eosin staining. Tissue sample sections were analyzed through light microscopy, and the lengths of at least 20 intestinal villi were measured in each group; the average number of crypts was obtained from 10 intestinal samples in each group. Microvessel density was assessed using CD31-positive (brown) vascular endothelial cells/cell clusters. FHs74Int cell proliferation was measured using the CCK-8 assay. PD administration (25 mg/kg) before IR was the most effective in prolonging the survival of C57BL/6 mice. PD reduced radiation-induced injury of intestinal villi, prevented loss of crypts, increased intestinal crypt growth, protected against IR-induced intestinal injury, and enhanced the proliferative potential and reduced the apoptosis of FHs74Int cells after IR. Moreover, PD increased small intestinal MVD and reduced the apoptosis of intestinal microvascular endothelial cells in mice after IR. Therefore, PD was found to be able to protect the two types of cells from radiation damage and to thus alleviate radiation-induced injury of small intestine.

Highlights

  • Gastrointestinal syndrome can be induced in cancer patients undergoing abdominal radiotherapy and in people accidentally exposed to abdominal irradiation (IR) [1]

  • This study aimed to examine the radioprotective effect of polydatin (PD) on crypt and endothelial cells of the small intestines of C57BL/6 mice that received abdominal irradiation (IR)

  • We examined the radioprotective effect of PD on crypt cells and endothelial cells of the small intestines of C57BL/6 mice that had received abdominal IR

Read more

Summary

Introduction

Gastrointestinal syndrome can be induced in cancer patients undergoing abdominal radiotherapy and in people accidentally exposed to abdominal irradiation (IR) [1]. There is, an urgent need to develop novel drugs that are effective in treating radiation-induced gastrointestinal syndrome [1]. Amifostine is the only radioprotective agent currently approved by the U.S Food and Drug Administration (FDA) for the prevention of radiation-induced severe toxic reactions. Polydatin (PD) is claimed to exhibit a wide spectrum of biomedical properties, including antiplatelet aggregation, antioxidant activity, cardioprotective effects, anti-inflammatory properties, and c 2018 The Author(s).

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call